Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs... Show more
The 50-day moving average for BMA moved below the 200-day moving average on June 27, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on July 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 10-day moving average for BMA crossed bearishly below the 50-day moving average on June 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BMA entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for BMA just turned positive on July 02, 2025. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 50, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (2.671) is very high in comparison to the industry average of (1.037). BMA has a moderately high P/E Ratio (89.758) as compared to the industry average of (16.999). Projected Growth (PEG Ratio) (0.468) is also within normal values, averaging (2.366). Dividend Yield (0.057) settles around the average of (0.059) among similar stocks. P/S Ratio (3.642) is also within normal values, averaging (2.929).
a regional bank
Industry RegionalBanks
A.I.dvisor indicates that over the last year, BMA has been closely correlated with GGAL. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMA jumps, then GGAL could also see price increases.
Ticker / NAME | Correlation To BMA | 1D Price Change % | ||
---|---|---|---|---|
BMA | 100% | -3.38% | ||
GGAL - BMA | 91% Closely correlated | -3.31% | ||
SUPV - BMA | 91% Closely correlated | -5.28% | ||
BBAR - BMA | 91% Closely correlated | -5.66% | ||
BAP - BMA | 40% Loosely correlated | -0.49% | ||
SBNY - BMA | 38% Loosely correlated | N/A | ||
More |